Check out these recently published Thyroid-related articles!

👉Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology. Adhami M, Michail P, Rao A, Bhatt CR, Grodski S, Serpell JW, Lee JC. World J Surg. 2019 Sep 9. PMID: 31502005 https://www.ncbi.nlm.nih.gov/pubmed/31502005

👉Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1. Gou L, Zou H, Li B. Cancer Biol Ther. 2019 Sep 10:1-11. PMID: 31500506 https://www.ncbi.nlm.nih.gov/pubmed/31500506

👉Thyroglobulin washout from cervical lymph node fine needle aspiration biopsies in patients with differentiated thyroid cancer: an analysis of different expressions to use in post-total thyroidectomy follow-up. Kahramangil B, Kose E, Donmez M, Aydin H, Reynolds JP, Krishnamurthy V, Jin J, Shin J, Siperstein A, Berber E. Surgery. 2019 Sep 5. PMID: 31495510 https://www.ncbi.nlm.nih.gov/pubmed/31495510

👉Impact of fluorescence and autofluorescence on surgical strategy in benign and malignant neck endocrine diseases. Rudin AV, Berber E. Best Pract Res Clin Endocrinol Metab. 2019 Aug 10:101311. PMID: 31494052 https://www.ncbi.nlm.nih.gov/pubmed/31494052

👉Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism. Edafe O, Mech CE, Balasubramanian SP. Cochrane Database Syst Rev. 2019 May 22;5. PMID: 31116878 https://www.ncbi.nlm.nih.gov/pubmed/31116878

👉Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up. Onuma AE, Beal EW, Nabhan F, Hughes T, Farrar WB, Phay J, Ringel MD, Kloos RT, Shirley LA. Ann Surg Oncol. 2019 Jun;26(6):1737-1743. PMID: 30820785 https://www.ncbi.nlm.nih.gov/pubmed/30820785

prof_739_20190417135234

  • Rodrigo Arrangoiz MS, MD, FACS miembro de Sociedad Quirúrgica S.C. es experto en el manejo de la patología de la glándula tiroides:
    • El Dr. Arrangoiz tiene entrenamiento en:
      • Cirugía de tumores de cabeza y cuello, cirugía endocrina, y cirugía oncológica.
  • Es pionero en México de la:
    • Cirugia tiroidea minimamente invasiva
    • La cirugia minimamente invasiva radio-guiada de paratiroides
  •  Su entrenamiento es el siguiente:
    • Tumores de Cabeza y Cuello / Cirugía Endocrina – Fox Chase Cancer Center

image-49

  • Tumores de Cabeza y Cuello / Cirugía Endocrina – IFHNOS / Memorial Sloan Kettering Cancer Center
  • Cirugía Oncológica Compleja – Fox Chase Cancer Center

image-39

 

  • Cirugia General y Gastrointestinal:
    • Michigan State University

images

  • Maestría en Ciencias de InvestigaciónDrexel University

image-40

  • El Dr. Arrangoiz esta certificado por:
    • El Colegio Americano de Cirugía

Unknown

 

  • Es fellow de la Sociedad de Cirugia Oncológica:

Unknown

  • Miembro de la American Thyroid Association:

Unknown

Sociedad Quirúrgica S.C.
Hospital ABC Santa Fé
Av. Carlos Graef Fernández #154
Consultorio 515
Col. Tlaxala, Delg. Cuajimalpa
México, D.F. 05300
Tel: 1103 – 1600 Ext 4515 a la 4517
Fax:1664 – 7164
rodrigo.arrangoiz@gmail.com

Leave a comment